Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag New Zealand begins two-year genomics pilot to cut cancer and rare disease test delays by processing tests locally.

flag New Zealand has launched a two-year pilot to bring genomic testing for cancer and rare disorders home, reducing reliance on overseas labs. flag The initiative, led by Health New Zealand and supported by Illumina, will process over 6,000 samples using whole genome and comprehensive genomic profiling, aiming to shift half of currently exported tests locally. flag It targets conditions like metabolic, connective tissue, eye, hearing, and kidney disorders, with cancer applications still being defined. flag The program seeks to cut patient wait times, improve diagnostic accuracy, build local expertise, and save about $5 million over five years. flag It also evaluates workforce readiness, operations, and data security to inform a future national genomics service. flag The launch coincides with Rare Disorders Month, highlighting the importance of timely diagnosis.

4 Articles